Correspondence

Journal of Veterinary Internal Medicine

Volumn 23, Issue 3, 2009, Pages 445-446

  Kittleson, Mark ^a   Rishniw, Mark ^b   Pion, Paul ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERINARY INFORMATION NETWORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BENZAZEPINE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; DOG; DOG DISEASE; METHODOLOGY; MITRAL VALVE REGURGITATION; NOTE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; DOG DISEASES; DOGS; MITRAL VALVE INSUFFICIENCY; RESEARCH DESIGN;

EID: 70350787172     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0294.x     Document Type: Letter

References (4)

1. Kvart C, Häggström J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:80-88.
2. Atkins CE, Keene BW, Brown WA, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc 2007;231:1061-1069.
3. Cheng M-Y, Hall P, Tu D. Confidence bands for hazard rates under random censorship. Biometrika 2006;93:357-366.
4. Borgarelli M, Savarino P, Crosara S, et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008;22:120-128.